Global Regenerative Medicine Market by Technology, By Source, By Application By End-Users and By Region
Bharat Book Bureau Provides the Trending Market Research Report on“Global Regenerative Medicine Market by Technology, By Source, By Application By End-Users and By Region�under Consumer Goods Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports. Global Regenerative Medicine Market by Technology (Cellular Therapy, Gene Therapy, Tissue Engineering, and Exosome Therapeutics), By Source (Autologous and Allogenic), By Application (Dermatology, Musculoskeletal, Oncology, Cardiovascular, Neurology, Hematology & Immunology, and Others), By End-Users(Hospitals, Ambulatory surgery centers (ASCs), Clinics and Others), and By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa) Global Regenerative Medicine Market expected to thrust by the rise in diseases related to aging and growing chronic diseases. The global Regenerative Medicine Market likely to gain noteworthy CAGR during the forecast period 2019-2027, owing to the rising government investments in regenerative medicine. Additionally, the spread of chronic diseases and the increasing elderly population will augment the global regenerative medicine market in the upcoming period. According to the International Agency for Research on Cancer (IARC), the global cancer burden estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. Globally, the total number of people who are alive within five years of a cancer diagnosis is estimated to be 43.8 million.
Request a free sample copy of Regenerative Medicine Market Report @ https://www.bharatbook.com/marketreports/sample/reports/1942067 According to Report, the proportion of the burden of non-communicable diseases expected to increase to 57% by 2020. Almost half of the total chronic disease deaths are attributable to cardiovascular diseases, obesity, and diabetes. It has projected that, by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide, and that 71% of deaths due to ischaemic heart disease (IHD), 75% of deaths due to stroke, and 70% of deaths due to diabetes will occur in developing countries. The growing application of regenerative medicine to address the rising prevalence of diseases such as Alzheimer's disease, Parkinson's disease, diabetes, heart disease, kidney failure, osteoporosis, and spinal cord injury projected to influence the global regenerative medicine market. Moreover, the surge in the applications of regenerative medicine for modifying chondrocytes, engineering cartilages, and other tissue engineering technologies for treatment of traumatic and degenerative joint diseases is estimated to boost the global regenerative medicine market in the future timeline. Further, the change in climatic conditions and an increase in sedentary lifestyles have led to demographic changes in developing and developed countries, resulting in the growing number of cases associated with aging. This aspect attributed to contributing considerably to the regenerative medicine market growth across the globe. According to the International Diabetes Federation (IDF), the worldwide prevalence of diabetes estimated at 463 million adults in the 20-79 age group. Technology Overview in the Global Regenerative Medicine Market Based on Technology, the global Regenerative Medicine Market categorized into Cellular Therapy, Gene Therapy, Tissue Engineering, and Exosome Therapeutics. The Cellular Therapy segment accounted for 48.53% market share in 2018 and is expected to dominate the market during the forecast period, 2019-2027. Owing to the growing application of cellular therapy for replacing the tissues and cells to treat various conditions, including arthritis, spinal cord injury, and Parkinson's disease, among others. Source Overview in the Global Regenerative Medicine Market Based on the Source, the Global Regenerative Medicine Market classified into Autologous and Allogenic. The Autologous segment estimated to exhibit 61.14% market share in 2018 and is projected to dominate the market, 2019-2027. Due to the minimization of risks from systemic immunological reactions, bio-incompatibility, and disease transmission. Application Overview in the Global Regenerative Medicine Market Based on the application, the Global Regenerative Medicine Market segregated into Dermatology, Musculoskeletal, Oncology, Cardiovascular, Neurology, Hematology &
Immunology, and Others. The oncology segment witnessed to exhibit 43.47% market share in 2018 and expected to lead the market in the estimated period, 2019-2027, owing to surge in cancer affected population resulted in the implementation of efficient cancer treatment options. End-User Overview in the Global Regenerative Medicine Market Based on End-user, the Global Regenerative Medicine market segregated into Hospitals, Ambulatory surgery centers (ASCs), Clinics, and Others. The Hospital segment generated the highest revenue with 52.46% market in 2018 and anticipated to dominate the market over the forecast period 2019-2027 attributable to the hospitals form a partnership with regenerative medicine manufacturing companies to provide cell therapy and tissue scaffolds to improve patient care and treatment. Regional Overview in the Global Regenerative Medicine Market By geography, the Global Regenerative Medicine Market segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America anticipated to exhibit 41.68% market share in 2018 and estimated to generate USD 66.57 Billion revenue by 2027 owing to the increasing prevalence of diseases, such as cancer and diabetes coupled with the availability of advanced technologies & the presence of research institutes and the rising initiatives by government and private organizations. Global Regenerative Medicine Market: Competitive Landscape Companies such as Integra LifeSciences Corporation, MiMedx Group, Inc., AstraZeneca, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Pfizer Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Medtronic Plc., Athersys Inc., US Stem Cell, Organogenesis Inc., Acelity Holdings Inc., Isto Biologics, Cryolife Inc. and Baxter are the key players in the Global Regenerative Medicine Market. Browse our full report with Table of Content : https://www.bharatbook.com/marketreports/global-regenerative-medicine-market-bytechnology-by-source-by-application-by-end-users-and-by-region/1942067 About Bharat Book Bureau: Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors. Contact us at: Bharat Book Bureau Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com Website: www.bharatbook.com